Outset Medical

Q2 FY2026 EarningsQ2 FY26 results beat consensus across key metrics, with revenue of $31.6M vs. $29.0M expected and a gross margin of 42.0% vs. the 43.5% mean. While total revenue grew just 1% YoY, a 17% surge in Service and Other revenue offset a 5% decline in Product revenue. Normalized EPS of -$0.97 beat the -$0.72 consensus (normalized comparison adjusted for share count), and the company successfully renegotiated debt covenants to provide more breathing room amid ongoing litigation and capital spending headwinds.